Literature DB >> 2354366

Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization.

B J Cole1, M Cador, L Stinus, J Rivier, W Vale, G F Koob, M Le Moal.   

Abstract

This experiment examined the effects of intracerebroventricular (i.c.v.) administration of a corticotropin-releasing factor (CRF) antagonist on the development of stress-induced sensitization of the behavioral response to amphetamine. Restraint stress was found to enhance both the locomotor response to a s.c. injection of saline and the intensity of stereotypy induced by a s.c. injection of 3.0 mg/kg D-amphetamine. Both of these effects of restraint stress were severely attenuated in rats that had been injected with the CRF antagonist prior to restraint stress. This result is compatible with the hypothesis that CRF is critically involved in initiating behavioral and physiological responses to aversive stimuli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354366     DOI: 10.1016/0006-8993(90)90646-S

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice.

Authors:  J R Fee; D R Sparta; M J Picker; T E Thiele
Journal:  Neuroscience       Date:  2007-09-08       Impact factor: 3.590

2.  Corticotropin-releasing factor, neuroplasticity (sensitization), and alcoholism.

Authors:  George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-26       Impact factor: 11.205

3.  The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.

Authors:  Sean C Godar; Laura J Mosher; Hunter J Strathman; Andrea M Gochi; Cori M Jones; Stephen C Fowler; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

Review 4.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

5.  Lost in Translation: CRF1 Receptor Antagonists and Addiction Treatment.

Authors:  Yavin Shaham; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2016-11       Impact factor: 7.853

6.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.

Authors:  L J Muglia; N A Jenkins; D J Gilbert; N G Copeland; J A Majzoub
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization.

Authors:  B M Prasad; C Ulibarri; P W Kalivas; B A Sorg
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

Review 8.  Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain.

Authors:  T Z Baram; C G Hatalski
Journal:  Trends Neurosci       Date:  1998-11       Impact factor: 13.837

Review 9.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

10.  Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nuclei.

Authors:  Maria A Esparza; Flavia Bollati; Constanza Garcia-Keller; Miriam B Virgolini; Lidia M Lopez; Alicia Brusco; Hao-Wei Shen; Peter W Kalivas; Liliana M Cancela
Journal:  Eur J Neurosci       Date:  2012-08-12       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.